Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

March 1, 2027

Conditions
Hypo-responderInfertility (IVF Patients)OVARIAN STIMULATION
Interventions
DRUG

use of combination of recombinant FSH and recombinant LH

in this arm the patients will use the combination of recFSH:recLH in the same dose as in her prior cycle

DRUG

higher dose recFSH

in this arm the patient will use an additional 75 IU/day recFSH compared to her previous drug dose

DRUG

unchanged dose

in this groups the patient will receive the same recFSH dose as in her prior cycle

Trial Locations (4)

1125

Dunamenti REK Istenhegyi IVF Center, Budapest

6723

University of Szeged, Reproductive Medicine Institute, Szeged

8300

Dunamenti REK Tapolca IVF Center, Tapolca

9026

Dunamenti REK Gyor IVF Center, Győr

All Listed Sponsors
collaborator

Dunamenti REK Gyor Clinic

UNKNOWN

collaborator

Dunamenti REK Pannon Clinic

UNKNOWN

collaborator

University of Szeged, Hungary

UNKNOWN

lead

Dunamenti REK Istenhegyi IVF Center

OTHER